Published in

Massachusetts Medical Society, New England Journal of Medicine, 6(390), p. 497-509, 2024

DOI: 10.1056/nejmoa2309000

Links

Tools

Export citation

Search in Google Scholar

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Journal article published in 2024 by Stephen A. Harrison, Pierre Bedossa, Cynthia D. Guy, Jörn M. Schattenberg ORCID, Rohit Loomba, Rebecca Taub ORCID, Dominic Labriola, Sam E. Moussa, Guy W. Neff, Mary E. Rinella, Quentin M. Anstee, Manal F. Abdelmalek, Zobair Younossi ORCID, Seth J. Baum, Sven Francque ORCID and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO